cytarabine and Emesis

cytarabine has been researched along with Emesis in 75 studies

Research

Studies (75)

TimeframeStudies, this research(%)All Research%
pre-199036 (48.00)18.7374
1990's17 (22.67)18.2507
2000's7 (9.33)29.6817
2010's12 (16.00)24.3611
2020's3 (4.00)2.80

Authors

AuthorsStudies
Ahern, K; Correia De Farias, M; Pham, J; Sanderson, R; Walsh, K1
Bonizzoni, E; Cascavilla, N; Celio, L; Dargenio, M; Di Renzo, N; Greco, G; Mannina, D; Matera, R; Mazza, P; Melillo, L; Merenda, A; Musso, M; Pastore, D; Pavone, V; Porretto, F1
Lertvivatpong, N; Monsereenusorn, C; Photia, A; Rujkijyanont, P; Ruktrirong, J; Traivaree, C1
Andrick, B; Clemmons, AB; DeRemer, D; Gandhi, A; Orr, J; Sportes, C1
Gwak, HS; Han, JY; Joo, J; Kim, HT; Kim, S; Lee, JS; Lee, SH; Shin, SH; Yoo, H1
Adès, L; Ame, S; Beyne-Rauzy, O; Braun, T; Charbonnier, A; Delaunay, J; Dreyfus, F; Fenaux, P; Prebet, T; Raffoux, E; Stammatoullas, A; Vey, N; Wattel, E1
He, H; Li, X; Li, XP; Li, Y; Liu, ZG; Liu, ZQ; Wang, Y; Xu, YJ; Yin, JY; Zhai, M; Zhang, Y; Zhou, F; Zhou, HH1
Badar, T; Borthakur, G; Cortes, J; Ferrajoli, A; Garcia-Manero, G; Kadia, T; Kantarjian, H; Mattiuzzi, G; O'Brien, S; Poku, R; Wierda, W1
Clark, SM; Clemmons, AB; DeRemer, DL; Garren, J; Kota, VK; Schaack, L1
Díaz-Carrasco, MS; Espuny-Miró, A; Galera-Miñarro, A; Olmos-Jiménez, R; Pascual-Gazquez, JF1
Apperley, JF; Auner, HW; Contento, A; Ellis, S; Giles, C; Kanfer, EJ; MacDonald, DH; Naresh, K; Pavlů, J; Rahemtulla, A; Szydlo, RM1
Bekele, BN; Blamble, DA; Borthakur, G; Cabanillas, M; Cortes, JE; Kantarjian, H; Mattiuzzi, GN; O'Brien, S; Xiao, L1
Barzal, J; Gawronski, K; Mlot, B; Oborska, S; Pielichowski, W; Rzepecki, P; Wasko-Grabowska, A1
Goto, T; Ishibashi, M; Okamura, S; Tanimoto, K1
D'Amore, ES; Finotto, S; Menin, A; Paolini, R; Pizzolo, G; Rodeghiero, F; Semenzato, G; Visco, C; Zaja, F; Zambello, R; Zanotti, R1
Amadori, S; Avvisati, G; Baccarani, M; Cantore, N; Di Bona, E; Ferrara, F; Fioritoni, G; Gallo, E; Invernizzi, R; Lazzarino, M; Liso, V; Lo-Coco, F; Mandelli, F; Mariani, G; Petti, MC; Ricciuti, F; Selleri, C; Sica, S; Vegna, ML; Veneri, D1
Guang, ZZ; He, YJ; Huang, HQ; Jiang, WQ; Li, YH; Lin, TY; Liu, DG; Sun, XF; Xu, GC; Xu, RH; Zhang, L; Zhou, ZM1
English, MW; Karandikar, SS; Sastry, J1
Forcier, RJ; LeMarbre, PA; Maurer, LH; O'Donnell, JF; Quinn, BM; Stern, R1
du Plessis, HE; Falkson, G; Falkson, HC; Meyer, TE1
Glick, JH; Hines, JD; Keller, AM; Mazza, JJ; Oken, MM; Streeter, RR1
Carpenter, J; Fishkin, E; Krauss, S; Moore, MR; Raab, S; Raney, M; Smalley, RV; Stagg, M; Velez-Garcia, E; Vogel, CL1
Marie, JP; Pochat, L; Pommier, Y; Zittoun, RA1
Altman, AJ; Dinndorf, P; Quinn, JJ1
Chavez, CM; Duncan, MH; Holdsworth, MT; Leasure, MM; Raisch, DW1
Baker, D; Fairclough, D; Mulhern, RK; Pui, CH; Relling, MV1
Gondo, H; Harada, M; Matsuishi, H; Omori, F; Otsuka, T; Shibuya, T; Taniguchi, S; Teshima, T; Yamano, Y; Yamazaki, K1
Fairclough, D; Longmire, W; Mulhern, RK; Relling, MV; Tyc, VL; Ward, PM1
Geissler, K; Gisslinger, H; Haas, OA; Huhmann, IM; Jäger, U; Kalhs, P; Knöbl, P; Korninger, L; Lechner, K; Mannhalter, C; Mitterbauer, G; Pabinger, I; Schwarzinger, I; Watzke, HH1
Sundström, GM; Wahlin, A1
Campbell, J; De La Serna, J; Diaz-Mediavilla, J; Francisco Tomás, J; García de Paredes, ML; Grande, C; Solano, C1
Chen, PM; Chiou, TJ; Fang, FS; Hsieh, RK; Liu, JH; Tung, SL; Tzeng, CH; Wang, WS; Yen, CC1
Beran, M; Estey, E; Jeha, S; Kantarjian, H; Keating, M; O'Brien, S; Rios, MB; Vitek, L; Zurlo, MG1
Miyata, Y; Saito, M; Takeyama, H; Yamada, H; Yamamoto, Y1
Kanamaru, A; Miyawaki, S; Mizoguchi, H; Nakamura, T; Ohashi, Y; Ohno, R; Tomonaga, M; Tsukagoshi, S; Yoshida, S1
Boerman, RH; Mattijssen, V; Mulder, AH; Raemaekers, JM1
Belt, R; Coon, J; Cord, M; Dix, S; Geller, R; Howard, S1
Klener, P; Procházka, B; Slabý, J; Trnený, M1
Aiken, R; Akerley, W; Allen, J; Baidas, S; Batchelor, T; Bent, MJ; Campbell, T; Chamberlain, MC; Cohn, A; Fulton, D; Gertler, SZ; Gilbert, M; Glantz, MJ; Greenberg, HS; Gutheil, JC; Heros, D; Howell, SB; Jaeckle, KA; LaFollette, S; Lesser, G; Maria, B; Mason, W; Moots, P; New, P; O'Day, SJ; Phuphanich, S; Recht, L; Rogers, L; Russell, C; Shapiro, W; Swinnen, L; Wong, E1
Guenther, PP; Huebner, A; Neumeister, V; Parwaresch, R; Sobottka, SB; Todt, H; Weissbach, G1
Atlas, MP; Giugliano, DM; Mahan, RA; Parker, RI; Prakash, D1
Bedwinek, J; Goldberg, RS; Joss, RA; Krakoff, IH; Yates, JW1
Brenning, G; Engstedt, L; Franzén, S; Gahrton, G; Gullbring, B; Höglund, S; Holm, G; Jameson, S; Killander, A; Killander, D; Lockner, D; Mellstedt, H; Palmblad, J; Reizenstein, P; Skårberg, KO; Swedberg, B; Udén, AM; Wadman, B; Wide, L1
Carden, PA; Ekert, H; Mitchell, SL; Tiedemann, K; Waters, KD1
Atkins, JN; Craig, JB; Goldklang, GA; Jackson, DV; Muss, HB; Powell, BL; Richards, F; Schnell, FM; Stuart, RK; White, DR1
Alvarado, C; Camitta, B; Fernbach, DJ; Krischer, J; Mahoney, DH; Tebbi, CK1
Büchner, T; Diedrich, H; Donhuijsen-Ant, R; Gerith-Stolzenburg, S; Heil, G; Hiddemann, W; Ho, AD; Maschmeyer, G; Planker, M; Schumacher, K1
Cleary, S; Howell, SB; Lucas, W; Markman, M; Weiss, R1
Grunberg, SM1
Booraem, CD; Flowers, JV; Gumbiner, J1
Bishop, JF; Cobcroft, R; Dodds, A; Joshua, DE; Kronenberg, H; Lowenthal, RM; Manoharan, A; Whiteside, MG; Wolf, M1
Cuttner, J; Dutcher, JP; Holland, JF; Paciucci, PA; Strauman, JJ; Wiernik, PH1
Civin, CI; Krischer, J; Land, VJ; Ragab, AH; Steuber, CP; Vietti, TJ1
Donnelly, H; Donner, AL; Fanucchi, M; Fox, J; Groshen, S; Leyland-Jones, B; Myskowski, P1
Capizzi, RL; Craig, JB; Powell, BL; White, DR1
Fibbe, WE; Kootte, AM; Lie, R; Peters, WG; Rodenburg, CJ; van Berkel, M; van Hennik, MB; Veltkamp, JJ; Willemze, R1
Lie, SO; Slørdahl, S1
Küchler, R; Kuse, R1
Markman, M1
Prentice, HG; Robbins, G; Wimperis, JZ1
Band, PR; Bernard, J; Holland, JF; Rall, D; Walker, M; Weil, M1
Avery, GB; Kraybill, EN; Movassaghi, N; Sever, JL1
Andrews, NC; Davis, HL; Madden, R; Rochlin, DB; Sedransk, N; Weiss, AJ; Wilson, WL1
Gunz, FW; Levi, JA; Vincent, PC1
Bodey, GP; Bonnet, JD; Coltman, CA; Freireich, EJ; Gehan, EA; Haut, AB; Hewlett, JS; McCredit, KB; Saiki, JH; Wilson, HE1
Armentrout, SA; Burns, CP1
Burningham, R; Falkson, G; Gailani, S; Holland, JF; Larsen, V; Leone, L1
Cohen, SM; Greenspan, EM; Weiner, MJ1
Bateman, CJ; Crowther, D; Fairley, GH; Malpas, JS; Scott, RB; Vartan, CP; Whitehouse, JM1
Bodey, GP; Freireich, EJ; Hart, J; Rodriguez, V1
Benoy, CJ; Elson, LA; Schneider, R1
Das, L; Dohlwitz, A; Hall, TC; Jaffe, N; Moloney, WC; Traggis, DG1
Buchanan, JG1
Blom, J; Burningham, R; Cuttner, J; Falkson, G; Glidewell, O; Holland, JF; Levy, RN; Moon, JH; Onuma, T; Rosner, F; Silver, RT1
Goldenberg, DM; Witte, S1

Reviews

2 review(s) available for cytarabine and Emesis

ArticleYear
Advances in the management of nausea and vomiting induced by non-cisplatin containing chemotherapeutic regimens.
    Blood reviews, 1989, Volume: 3, Issue:4

    Topics: Adrenal Cortex Hormones; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Benzodiazepines; Cannabinoids; Cytarabine; Dopamine Antagonists; Humans; Metoclopramide; Nausea; Phenothiazines; Serotonin Antagonists; Vomiting

1989
The intracavitary administration of cytarabine to patients with nonhematopoietic malignancies: pharmacologic rationale and results of clinical trials.
    Seminars in oncology, 1985, Volume: 12, Issue:2 Suppl 3

    Topics: Abdomen; Antineoplastic Combined Chemotherapy Protocols; Cell Line; Cisplatin; Cytarabine; Dose-Response Relationship, Drug; Doxorubicin; Drug Evaluation; Female; Humans; Kidney Diseases; Kinetics; Leukopenia; Nausea; Neoplasms; Ovarian Neoplasms; Pain; Peritoneal Cavity; Peritonitis; Pleura; Thrombocytopenia; Vomiting

1985

Trials

35 trial(s) available for cytarabine and Emesis

ArticleYear
Every-other-day palonosetron plus aprepitant for prevention of emesis following induction chemotherapy for acute myeloid leukemia: A randomized, controlled study from the "Rete Ematologica Pugliese".
    Cancer medicine, 2020, Volume: 9, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Anthracyclines; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Aprepitant; Cytarabine; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Induction Chemotherapy; Leukemia, Myeloid, Acute; Male; Middle Aged; Nausea; Palonosetron; Treatment Failure; Vomiting; Young Adult

2020
Single daily dosing versus divided dosing intravenous ondansetron to prevent chemotherapy-induced nausea and vomiting among children: A comparative randomized double-blind controlled trial.
    Pediatric blood & cancer, 2021, Volume: 68, Issue:6

    Topics: Adolescent; Antiemetics; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cytarabine; Double-Blind Method; Female; Hematologic Neoplasms; Humans; Hydrocortisone; Infant; Infant, Newborn; Male; Methotrexate; Nausea; Ondansetron; Prospective Studies; Vomiting

2021
Randomized, Placebo-Controlled, Phase III Trial of Fosaprepitant, Ondansetron, Dexamethasone (FOND) Versus FOND Plus Olanzapine (FOND-O) for the Prevention of Chemotherapy-Induced Nausea and Vomiting in Patients with Hematologic Malignancies Receiving Hig
    Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 2018, Volume: 24, Issue:10

    Topics: Adult; Aged; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cytarabine; Female; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Induction Chemotherapy; Male; Melphalan; Middle Aged; Morpholines; Nausea; Olanzapine; Ondansetron; Podophyllotoxin; Vomiting

2018
Combination of vorinostat and low dose cytarabine for patients with azacitidine-refractory/relapsed high risk myelodysplastic syndromes.
    Leukemia research, 2014, Volume: 38, Issue:1

    Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Azacitidine; Cytarabine; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Resistance, Neoplasm; Female; Humans; Hydroxamic Acids; In Vitro Techniques; Middle Aged; Myelodysplastic Syndromes; Nausea; Neutropenia; Recurrence; Risk Factors; Survival Analysis; Thrombocytopenia; Treatment Outcome; Vomiting; Vorinostat

2014
Phase II, open label, randomized comparative trial of ondansetron alone versus the combination of ondansetron and aprepitant for the prevention of nausea and vomiting in patients with hematologic malignancies receiving regimens containing high-dose cytara
    BioMed research international, 2015, Volume: 2015

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Aprepitant; Cytarabine; Dose-Response Relationship, Drug; Female; Hematologic Neoplasms; Humans; Male; Middle Aged; Morpholines; Nausea; Ondansetron; Treatment Outcome; Vomiting

2015
Daily palonosetron is superior to ondansetron in the prevention of delayed chemotherapy-induced nausea and vomiting in patients with acute myelogenous leukemia.
    Cancer, 2010, Dec-15, Volume: 116, Issue:24

    Topics: Adult; Aged; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Drug Administration Schedule; Female; Humans; Isoquinolines; Leukemia, Myeloid, Acute; Male; Middle Aged; Nausea; Ondansetron; Palonosetron; Quinuclidines; Serotonin Antagonists; Vomiting

2010
A triple-drug combination to prevent nausea and vomiting following BEAM chemotherapy before autologous hematopoietic stem cell transplantation.
    Transplantation proceedings, 2011, Volume: 43, Issue:8

    Topics: Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Aprepitant; Carmustine; Cytarabine; Dexamethasone; Drug Therapy, Combination; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Isoquinolines; Lymphoma, Non-Hodgkin; Male; Melphalan; Morpholines; Nausea; Ondansetron; Palonosetron; Quinuclidines; Transplantation, Autologous; Treatment Outcome; Vomiting

2011
Combination of rituximab, bendamustine, and cytarabine for patients with mantle-cell non-Hodgkin lymphoma ineligible for intensive regimens or autologous transplantation.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2013, Apr-10, Volume: 31, Issue:11

    Topics: Aged; Aged, 80 and over; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Bendamustine Hydrochloride; Cytarabine; Drug Administration Schedule; Fatigue; Female; Humans; Kaplan-Meier Estimate; Leukopenia; Lymphoma, Mantle-Cell; Male; Middle Aged; Nausea; Neutropenia; Nitrogen Mustard Compounds; Positron-Emission Tomography; Remission Induction; Rituximab; Transplantation, Autologous; Treatment Outcome; Vomiting

2013
Induction therapy with idarubicin alone significantly influences event-free survival duration in patients with newly diagnosed hypergranular acute promyelocytic leukemia: final results of the GIMEMA randomized study LAP 0389 with 7 years of minimal follow
    Blood, 2002, Nov-01, Volume: 100, Issue:9

    Topics: Adolescent; Adult; Age Factors; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Chemical and Drug Induced Liver Injury; Child; Cytarabine; Disease-Free Survival; Female; Follow-Up Studies; Hemorrhage; Humans; Idarubicin; Infections; Leukemia, Promyelocytic, Acute; Leukocyte Count; Male; Mercaptopurine; Methotrexate; Middle Aged; Remission Induction; Treatment Outcome; Vomiting

2002
[Preliminary study on DHAP regimen for patients with relapsed and refractory non-Hodgkin's lymphoma].
    Ai zheng = Aizheng = Chinese journal of cancer, 2002, Volume: 21, Issue:8

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Cisplatin; Cytarabine; Dexamethasone; Female; Fever; Humans; Leukopenia; Lymphoma, Non-Hodgkin; Male; Middle Aged; Nausea; Neoplasm Recurrence, Local; Survival Rate; Treatment Outcome; Vomiting

2002
Intensive cytosine arabinoside therapy in small cell carcinoma of the lung.
    American journal of clinical oncology, 1984, Volume: 7, Issue:5

    Topics: Aged; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Clinical Trials as Topic; Cyclophosphamide; Cytarabine; Doxorubicin; Female; Humans; Infusions, Parenteral; Lung Neoplasms; Male; Middle Aged; Nausea; Thrombocytopenia; Vincristine; Vomiting

1984
Randomized trial of cyclophosphamide, doxorubicin, and 5-fluorouracil alone or alternating with a "cycle active" non-cross-resistant combination in women with visceral metastatic breast cancer: a Southeastern Cancer Study Group project.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1984, Volume: 2, Issue:6

    Topics: Agranulocytosis; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Clinical Trials as Topic; Cyclophosphamide; Cytarabine; Doxorubicin; Drug Administration Schedule; Drug Resistance; Female; Fluorouracil; Humans; Leucovorin; Liver Neoplasms; Lung Neoplasms; Methotrexate; Nausea; Random Allocation; Thrombocytopenia; Vincristine; Vomiting

1984
Chlorpromazine with and without lorazepam as antiemetic therapy in children receiving uniform chemotherapy.
    The Journal of pediatrics, 1993, Volume: 123, Issue:5

    Topics: Adolescent; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Chlorpromazine; Cytarabine; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Infant; Lorazepam; Male; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Remission Induction; Teniposide; Vomiting

1993
[Study on the inhibitory effect of oral granisetron against nausea/vomiting induced by cytosine arabinoside containing chemotherapy for tumors in the hematopoietic organs].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1993, Volume: 20, Issue:10

    Topics: Administration, Oral; Adult; Aged; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Daunorubicin; Etoposide; Female; Granisetron; Humans; Indazoles; Lymphoma; Male; Middle Aged; Mitoxantrone; Nausea; Vomiting

1993
Chemotherapy induced nausea and emesis in pediatric cancer patients: external validity of child and parent emesis ratings.
    Journal of developmental and behavioral pediatrics : JDBP, 1993, Volume: 14, Issue:4

    Topics: Adolescent; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Anxiety; Attitude; Child; Child, Preschool; Cytarabine; Double-Blind Method; Female; Humans; Infant; Male; Nausea; Parents; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Severity of Illness Index; Sick Role; Teniposide; Vomiting

1993
Comparison of efficacies of ondansetron and dixyrazine for prophylaxis of emesis during induction treatment in acute myelogenous leukemia. A pilot study.
    Acta oncologica (Stockholm, Sweden), 1997, Volume: 36, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Amsacrine; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Daunorubicin; Female; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Ondansetron; Phenothiazines; Pilot Projects; Serotonin Antagonists; Vomiting

1997
Idarubicin and intermediate dose ARA-C followed by consolidation chemotherapy or bone marrow transplantation in relapsed or refractory acute myeloid leukemia.
    Leukemia & lymphoma, 1997, Volume: 25, Issue:3-4

    Topics: Acute Disease; Adult; Agranulocytosis; Antibiotics, Antineoplastic; Bone Marrow Transplantation; Cytarabine; Disease-Free Survival; Dose-Response Relationship, Drug; Female; Humans; Idarubicin; Leukemia, Myeloid; Leukemia, Myeloid, Acute; Male; Nausea; Remission Induction; Thrombocytopenia; Treatment Outcome; Vomiting

1997
Navoban (tropisetron, ICS 205-930) and dexamethasone combination in the prevention of vomiting for patients receiving preconditioning high-dose chemotherapy before marrow transplantation.
    Japanese journal of clinical oncology, 1998, Volume: 28, Issue:2

    Topics: Adolescent; Adult; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Busulfan; Carmustine; Child; Cyclophosphamide; Cytarabine; Dexamethasone; Dizziness; Drug Therapy, Combination; Female; Headache; Heartburn; Humans; Indoles; Leukemia; Male; Melphalan; Middle Aged; Multiple Myeloma; Podophyllotoxin; Transplantation Conditioning; Tropisetron; Vomiting; Whole-Body Irradiation

1998
Tallimustine, an effective antileukemic agent in a severe combined immunodeficient mouse model of adult myelogenous leukemia, induces remissions in a phase I study.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 1997, Volume: 3, Issue:12 Pt 1

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Animals; Antineoplastic Agents; Cytarabine; Diarrhea; Distamycins; Drug Administration Schedule; Female; Humans; Injections, Intravenous; Leukemia; Leukemia, Myeloid, Acute; Leukemia, Myelomonocytic, Acute; Mice; Mice, SCID; Middle Aged; Nausea; Nitrogen Mustard Compounds; Transplantation, Heterologous; Tumor Cells, Cultured; Vomiting

1997
[Efficacy of granisetron in the prevention of emesis induced by conditioning chemotherapy for allogeneic bone marrow transplantation].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1998, Volume: 25, Issue:13

    Topics: Adolescent; Adult; Antiemetics; Bone Marrow Transplantation; Cyclophosphamide; Cytarabine; Female; Granisetron; Hematologic Neoplasms; Humans; Male; Middle Aged; Transplantation Conditioning; Vomiting; Whole-Body Irradiation

1998
[A phase II study with high-dose cytarabine (NS-075) in adult patients with relapsed and refractory acute leukemia].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1998, Volume: 25, Issue:14

    Topics: Adolescent; Adult; Aged; Anorexia; Antimetabolites, Antineoplastic; Cytarabine; Diarrhea; Drug Administration Schedule; Female; Humans; Infusions, Intravenous; Leukemia, Myeloid, Acute; Male; Middle Aged; Nausea; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Vomiting

1998
Antiemetic efficacy of three serotonin antagonists during high-dose chemotherapy and autologous stem cell transplantation in malignant lymphoma.
    Neoplasma, 2000, Volume: 47, Issue:5

    Topics: Adult; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Combined Modality Therapy; Cytarabine; Etoposide; Female; Granisetron; Hematopoietic Stem Cell Transplantation; Humans; Indoles; Lymphoma; Male; Melphalan; Nausea; Ondansetron; Serotonin Antagonists; Transplantation, Autologous; Tropisetron; Vomiting

2000
Intrathecal treatment of neoplastic meningitis due to breast cancer with a slow-release formulation of cytarabine.
    British journal of cancer, 2001, Volume: 84, Issue:2

    Topics: Adult; Aged; Antimetabolites, Antineoplastic; Arachnoiditis; Breast Neoplasms; Cohort Studies; Cytarabine; Delayed-Action Preparations; Female; Headache; Humans; Injections, Spinal; Meningeal Neoplasms; Middle Aged; Nausea; Survival Analysis; Treatment Outcome; Treatment Refusal; Vomiting

2001
Randomized, double-blind, crossover, placebo-controlled trial of intravenous ondansetron for the prevention of intrathecal chemotherapy-induced vomiting in children.
    Journal of pediatric hematology/oncology, 2001, Volume: 23, Issue:9

    Topics: Adolescent; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cross-Over Studies; Cytarabine; Dose-Response Relationship, Drug; Double-Blind Method; Female; Headache; Humans; Hydrocortisone; Injections, Intravenous; Leukemia; Male; Mercaptopurine; Methotrexate; Nausea; Ondansetron; Risk; Serotonin Antagonists; Treatment Outcome; Vincristine; Vomiting

2001
L-asparaginase and prednisolone pretreatment followed by rubidomycin and cytosine arabinoside for induction of remission in adult patients with acute myeloblastic leukaemia.
    Scandinavian journal of haematology, 1975, Volume: 15, Issue:1

    Topics: Adolescent; Adult; Age Factors; Aged; Asparaginase; Cytarabine; Daunorubicin; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Leukemia, Myeloid, Acute; Leukocyte Count; Male; Middle Aged; Nausea; Prednisolone; Remission, Spontaneous; Vomiting

1975
Prevention of cyclophosphamide/cytarabine-induced emesis with ondansetron in children with leukemia.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1990, Volume: 8, Issue:9

    Topics: Administration, Oral; Adolescent; Adult; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Drug Evaluation; Female; Humans; Imidazoles; Injections, Intravenous; Liver Function Tests; Male; Ondansetron; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Serotonin Antagonists; Vomiting

1990
Toxicity of high-dose cytosine arabinoside in the treatment of advanced childhood tumors resistant to conventional therapy. A Pediatric Oncology Group study.
    Cancer, 1990, Nov-15, Volume: 66, Issue:10

    Topics: Child; Cytarabine; Drug Administration Schedule; Fibrosarcoma; Humans; Infusions, Intravenous; Nausea; Neoplasms; Neuroblastoma; Pilot Projects; Rhabdomyosarcoma; Vomiting

1990
Ip chemotherapy employing a regimen of cisplatin, cytarabine, and bleomycin.
    Cancer treatment reports, 1986, Volume: 70, Issue:6

    Topics: Abdominal Neoplasms; Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Catheters, Indwelling; Cisplatin; Clinical Trials as Topic; Cytarabine; Drug Administration Schedule; Female; Humans; Injections, Intraperitoneal; Laparotomy; Male; Middle Aged; Ovarian Neoplasms; Pain; Peritoneal Cavity; Solutions; Vomiting

1986
2'-Fluoro-5-iodoarabinosylcytosine, a new potent antiviral agent: efficacy in immunosuppressed individuals with herpes zoster.
    The Journal of infectious diseases, 1986, Volume: 154, Issue:3

    Topics: Adolescent; Adult; Aged; Antiviral Agents; Chemical Phenomena; Chemistry; Child; Clinical Trials as Topic; Cytarabine; Double-Blind Method; Female; Herpes Zoster; Humans; Immune Tolerance; Male; Middle Aged; Nausea; Neoplasms; Random Allocation; Vidarabine; Vomiting

1986
Antiemetic therapy in patients treated with high-dose cytosine arabinoside.
    Oncology, 1987, Volume: 44, Issue:2

    Topics: Adolescent; Adult; Aged; Basal Ganglia Diseases; Clinical Trials as Topic; Cytarabine; Drug Therapy, Combination; Female; Humans; Lorazepam; Male; Metoclopramide; Middle Aged; Nausea; Time Factors; Vomiting

1987
Sequential studies on the role of mitoxantrone in the treatment of acute leukemia.
    Investigational new drugs, 1985, Volume: 3, Issue:2

    Topics: Acute Disease; Adolescent; Adult; Aged; Agranulocytosis; Anthraquinones; Antineoplastic Agents; Bone Marrow Transplantation; Clinical Trials as Topic; Cytarabine; Female; Heart; Humans; Leukemia; Leukemia, Myeloid; Male; Middle Aged; Mitoxantrone; Nausea; Stroke Volume; Vomiting

1985
Chemotherapy of acute leukemia. Comparison of cytarabine alone and in combination with vincristine, prednisone, and cyclophosphamide.
    Archives of internal medicine, 1974, Volume: 133, Issue:2

    Topics: Acute Disease; Adolescent; Adult; Age Factors; Aged; Anemia; Chemical and Drug Induced Liver Injury; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Drug Therapy, Combination; Female; Humans; Leukemia; Leukemia, Lymphoid; Leukemia, Myeloid, Acute; Leukocyte Count; Leukopenia; Male; Middle Aged; Nausea; Prednisone; Time Factors; Vincristine; Vomiting

1974
Comparison of treatment of metastatic gastrointestinal cancer with 5-fluorouracil (5-FU) to a combination of 5-FU with cytosine arabinoside.
    Cancer, 1972, Volume: 29, Issue:5

    Topics: Adenocarcinoma; Clinical Trials as Topic; Colonic Neoplasms; Cytarabine; Diabetic Ketoacidosis; Diarrhea; Drug Combinations; Evaluation Studies as Topic; Fluorouracil; Gastrointestinal Neoplasms; Humans; Leukopenia; Placebos; Stomach Neoplasms; Thrombocytopenia; Vomiting

1972
Combination chemotherapy using L-asparaginase, daunorubicin, and cytosine arabinoside in adults with acute myelogenous leukaemia.
    British medical journal, 1970, Nov-28, Volume: 4, Issue:5734

    Topics: Adolescent; Adult; Aged; Asparaginase; Blood Cell Count; Clinical Trials as Topic; Cytarabine; Daunorubicin; Edema; Female; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Nausea; Serum Albumin; Vomiting

1970
Therapy of acute leukemia with the combination of cytosine arabinoside (NSC-63878) and cyclophosphamide (NSC-26271).
    Cancer chemotherapy reports, 1970, Volume: 54, Issue:4

    Topics: Acute Disease; Adolescent; Adult; Aged; Alanine Transaminase; Alopecia; Aspartate Aminotransferases; Bone Marrow Diseases; Child; Clinical Trials as Topic; Cyclophosphamide; Cystitis; Cytarabine; Drug Combinations; Evaluation Studies as Topic; Female; Humans; Leukemia; Leukemia, Lymphoid; Leukemia, Myeloid; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Nausea; Remission, Spontaneous; Vomiting

1970

Other Studies

38 other study(ies) available for cytarabine and Emesis

ArticleYear
The nutritional impact of CD19-targeted CAR-T therapy versus BEAM chemotherapy for adult patients with lymphoma.
    Journal of human nutrition and dietetics : the official journal of the British Dietetic Association, 2023, Volume: 36, Issue:5

    Topics: Adult; Antigens, CD19; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cytarabine; Humans; Immunotherapy, Adoptive; Lymphoma; Mucositis; Nausea; Neoplasm Recurrence, Local; Receptors, Chimeric Antigen; Vomiting; Weight Loss

2023
Analysis of treatment outcomes of intraventricular chemotherapy in 105 patients for leptomeningeal carcinomatosis from non-small-cell lung cancer.
    Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, 2013, Volume: 8, Issue:5

    Topics: Adult; Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cranial Nerve Diseases; Cytarabine; Erlotinib Hydrochloride; Female; Gefitinib; Headache; Humans; Hydrocortisone; Infusions, Intraventricular; Intracranial Pressure; Karnofsky Performance Status; Lung Neoplasms; Male; Meningeal Carcinomatosis; Mental Disorders; Methotrexate; Middle Aged; Nausea; Palliative Care; Protein Kinase Inhibitors; Quinazolines; Retrospective Studies; Vomiting

2013
Association of ABCB1 polymorphisms with the efficacy of ondansetron in chemotherapy-induced nausea and vomiting.
    Clinical therapeutics, 2014, Aug-01, Volume: 36, Issue:8

    Topics: Adolescent; Adult; Alleles; Antiemetics; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; ATP Binding Cassette Transporter, Subfamily B; Cytarabine; Cytochrome P-450 CYP2D6; Drug Resistance; Female; Haplotypes; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Nausea; Ondansetron; Polymorphism, Single Nucleotide; Vomiting; Young Adult

2014
Fosaprepitant for the prevention of nausea and vomiting in patients receiving BEAM or high-dose melphalan before autologous hematopoietic stem cell transplant.
    Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners, 2016, Volume: 22, Issue:3

    Topics: Aged; Antiemetics; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cohort Studies; Cytarabine; Female; Hematopoietic Stem Cell Transplantation; Humans; Male; Melphalan; Middle Aged; Morpholines; Nausea; Podophyllotoxin; Prospective Studies; Retrospective Studies; Transplantation Conditioning; Vomiting

2016
Evaluation of standardized triple intrathecal therapy toxicity in oncohematological pediatric patients.
    International journal of clinical pharmacy, 2017, Volume: 39, Issue:1

    Topics: Adrenal Cortex Hormones; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cohort Studies; Cytarabine; Female; Headache; Hematologic Neoplasms; Humans; Injections, Spinal; Male; Methotrexate; Prospective Studies; Vomiting

2017
LACE-conditioned autologous stem cell transplantation for relapsed or refractory diffuse large B-cell lymphoma: treatment outcome and risk factor analysis from a single centre.
    Hematological oncology, 2011, Volume: 29, Issue:2

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Diarrhea; Drug Resistance, Neoplasm; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Lomustine; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Recurrence; Stomatitis; Survival Analysis; Transplantation Conditioning; Transplantation, Autologous; Treatment Outcome; Vomiting; Young Adult

2011
[Efficacy of granisetron for preventing chemotherapy-induced nausea and vomiting in patients with acute myelogenous leukemia treated with a combination of anthracycline and cytarabine].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2012, Volume: 39, Issue:8

    Topics: Adult; Aged; Aged, 80 and over; Anthracyclines; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Constipation; Cytarabine; Female; Granisetron; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Nausea; Retrospective Studies; Vomiting; Young Adult

2012
Benign intracranial hypertension in association with acute lymphoblastic leukemia.
    Pediatric hematology and oncology, 2003, Volume: 20, Issue:2

    Topics: Acetazolamide; Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Chlorthalidone; Cyclophosphamide; Cytarabine; Daunorubicin; Diagnosis, Differential; Headache; Humans; Intracranial Hypertension; Male; Mercaptopurine; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Sinus Thrombosis, Intracranial; Vincristine; Vomiting

2003
Anhydro-ara-5-fluorocytidine (AAFC) in gastrointestinal cancer. A phase II study.
    Cancer clinical trials, 1980, Volume: 3, Issue:4

    Topics: Ancitabine; Antineoplastic Agents; Cytarabine; Drug Evaluation; Female; Gastrointestinal Neoplasms; Humans; Leukopenia; Male; Nausea; Vomiting

1980
High-dose cytosine arabinoside and m-AMSA is effective therapy in relapsed acute nonlymphocytic leukemia.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1984, Volume: 2, Issue:6

    Topics: Acute Disease; Adolescent; Adult; Aged; Aminoacridines; Amsacrine; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Cytarabine; Drug Eruptions; Hemorrhage; Humans; Leukemia; Middle Aged; Nausea; Recurrence; Vomiting

1984
High-dose cytarabine in acute leukemia: toxicity and pharmacokinetics.
    Cancer treatment reports, 1983, Volume: 67, Issue:4

    Topics: Acute Disease; Adolescent; Adult; Cytarabine; Cytidine Deaminase; Female; Half-Life; Humans; Kinetics; Leukemia; Leukocyte Count; Male; Middle Aged; Nausea; Nucleoside Deaminases; Vomiting

1983
Acute pancreatitis in association with cytosine arabinoside therapy.
    Cancer, 1982, Apr-01, Volume: 49, Issue:7

    Topics: Acute Disease; Adolescent; Anorexia; Asparaginase; Cytarabine; Humans; Leukemia, Lymphoid; Male; Pain; Pancreatitis; Time Factors; Ultrasonography; Vomiting

1982
Assessment of chemotherapy-induced emesis and evaluation of a reduced-dose intravenous ondansetron regimen in pediatric outpatients with leukemia.
    The Annals of pharmacotherapy, 1995, Volume: 29, Issue:1

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cytarabine; Etoposide; Female; Humans; Infusions, Intravenous; Male; Nausea; Ondansetron; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Severity of Illness Index; Vomiting

1995
FLAG (fludarabine, cytosine arabinoside, G-CSF) for refractory and relapsed acute myeloid leukemia.
    Annals of hematology, 1996, Volume: 73, Issue:6

    Topics: Acute Disease; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Central Nervous System Diseases; Cytarabine; Female; Granulocyte Colony-Stimulating Factor; Humans; Leukemia, Myeloid; Male; Middle Aged; Nausea; Neutropenia; Treatment Outcome; Vidarabine; Vomiting

1996
Downbeat nystagmus caused by thiamine deficiency: an unusual presentation of CNS localization of large cell anaplastic CD 30-positive non-Hodgkin's lymphoma.
    Annals of hematology, 1999, Volume: 78, Issue:2

    Topics: Adult; Anisocoria; Antineoplastic Combined Chemotherapy Protocols; Aphasia; Bleomycin; Brain Neoplasms; Cyclophosphamide; Cytarabine; Dizziness; Doxorubicin; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Hemiplegia; Humans; Lymphoma, Large-Cell, Anaplastic; Methotrexate; Mitoxantrone; Neoplastic Stem Cells; Nystagmus, Pathologic; Prednisone; Remission Induction; Thiamine; Vincristine; Vomiting; Wernicke Encephalopathy

1999
Safety and efficacy of a continuous infusion, patient controlled anti-emetic pump to facilitate outpatient administration of high-dose chemotherapy.
    Bone marrow transplantation, 1999, Volume: 24, Issue:5

    Topics: Adult; Ambulatory Care; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carboplatin; Carmustine; Cyclophosphamide; Cytarabine; Dexamethasone; Diphenhydramine; Etoposide; Evaluation Studies as Topic; Female; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Humans; Infusion Pumps; Infusions, Intravenous; Lorazepam; Lymphoma, Non-Hodgkin; Male; Middle Aged; Multiple Myeloma; Nausea; Patient Acceptance of Health Care; Prospective Studies; Safety; Self Care; Thiotepa; Vomiting

1999
Temporary response of localized intracranial mast cell sarcoma to combination chemotherapy.
    Journal of pediatric hematology/oncology, 2001, Volume: 23, Issue:2

    Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Combined Modality Therapy; Cranial Irradiation; Cytarabine; Daunorubicin; Disease Progression; Etoposide; Fatal Outcome; Female; Headache; Humans; Immunologic Factors; Injections, Spinal; Interferon alpha-2; Interferon-alpha; Mast-Cell Sarcoma; Nausea; Neoplasm Recurrence, Local; Palliative Care; Papilledema; Parietal Lobe; Prednisolone; Radioisotope Teletherapy; Recombinant Proteins; Remission Induction; Supratentorial Neoplasms; Temporal Lobe; Treatment Failure; Vomiting

2001
Combination radiotherapy and chemotherapy for small cell carcinoma of the lung.
    Medical and pediatric oncology, 1979, Volume: 7, Issue:3

    Topics: Alopecia; Antineoplastic Agents; Arrhythmias, Cardiac; Carcinoma, Small Cell; Cyclophosphamide; Cytarabine; Doxorubicin; Drug Evaluation; Drug Therapy, Combination; Humans; Leukopenia; Lung Neoplasms; Methotrexate; Middle Aged; Vomiting

1979
A phase II trial of high-dose cytarabine and cisplatin in previously untreated non-small cell carcinoma of the lung. A Piedmont Oncology Association Study.
    Cancer, 1990, Apr-15, Volume: 65, Issue:8

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Carcinoma, Non-Small-Cell Lung; Cisplatin; Cytarabine; Drug Evaluation; Female; Follow-Up Studies; Humans; Lung Neoplasms; Male; Middle Aged; Nausea; Remission Induction; Vomiting

1990
Treatment of refractory acute lymphoblastic leukemia in adults with high dose cytosine arabinoside and mitoxantrone (HAM).
    Leukemia, 1990, Volume: 4, Issue:9

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Combined Modality Therapy; Cytarabine; Diarrhea; Drug Evaluation; Female; Humans; Male; Middle Aged; Mitoxantrone; Nausea; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Remission Induction; Vomiting

1990
Combined medical and psychological treatment of postchemotherapy nausea and vomiting: a case study.
    Psychological reports, 1989, Volume: 65, Issue:1

    Topics: Acute Disease; Behavior Therapy; Combined Modality Therapy; Cytarabine; Diazepam; Flurazepam; Humans; Leukemia; Male; Middle Aged; Nausea; Vomiting

1989
A phase I-II study of cytosine arabinoside, daunorubicin, and VP16-213 in adult patients with acute non-lymphocytic leukemia.
    Australian and New Zealand journal of medicine, 1986, Volume: 16, Issue:1

    Topics: Acute Disease; Adult; Aged; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Daunorubicin; Drug Evaluation; Etoposide; Female; Humans; Leukemia; Male; Middle Aged; Nausea; Stomatitis; Vomiting

1986
Mitoxantrone and ara-C in previously treated patients with acute myelogenous leukemia.
    Leukemia, 1987, Volume: 1, Issue:7

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Cytarabine; Diarrhea; Drug Administration Schedule; Female; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Mitoxantrone; Nausea; Vomiting

1987
Toxicity evaluation of dihydroxyanthracenedione (DHAD) in combination with cytosine arabinoside (Ara-C).
    Investigational new drugs, 1987, Volume: 5, Issue:4

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cytarabine; Heart Diseases; Humans; Infant; Infusions, Intravenous; Leukemia, Lymphoid; Leukemia, Myeloid; Mitoxantrone; Nausea; Pancytopenia; Vomiting

1987
Intermediate and high-dose ARA-C and m-AMSA (or daunorubicin) as remission and consolidation treatment for patients with relapsed acute leukaemia and lymphoblastic non-Hodgkin lymphoma.
    Scandinavian journal of haematology, 1985, Volume: 34, Issue:1

    Topics: Adolescent; Adult; Aminoacridines; Amsacrine; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Daunorubicin; Fever; Humans; Intercalating Agents; Intestinal Obstruction; Leukemia, Myeloid, Acute; Lymphoma, Non-Hodgkin; Middle Aged; Nausea; Time Factors; Vomiting

1985
High-dose cytosine arabinoside in the treatment of childhood malignancies.
    Seminars in oncology, 1985, Volume: 12, Issue:2 Suppl 3

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Diseases; Child; Child, Preschool; Cytarabine; Diterpenes; Doxorubicin; Female; Humans; Infant; Leukemia, Lymphoid; Leukemia, Myeloid, Acute; Lymphoma; Male; Pancytopenia; Recurrence; Retinyl Esters; Vitamin A; Vomiting

1985
[Non-hematologic toxicity in high-dose cytarabine therapy].
    Onkologie, 1985, Volume: 8, Issue:1

    Topics: Acute Disease; Antineoplastic Combined Chemotherapy Protocols; Brain Diseases; Cytarabine; Dose-Response Relationship, Drug; Humans; Keratitis; Leukemia; Skin Diseases; Vomiting

1985
Treatment of central nervous system leukemia with intrathecal cytosine arabinoside.
    Cancer, 1973, Volume: 32, Issue:4

    Topics: Adolescent; Adult; Animals; Brain Neoplasms; Child; Child, Preschool; Cytarabine; Dogs; Female; Haplorhini; Headache; Humans; Injections, Spinal; Leukemia; Leukemia, Lymphoid; Leukemia, Myeloid; Lymphoma, Non-Hodgkin; Male; Meninges; Middle Aged; Vomiting

1973
Experimental use of cytosine arabinoside in congenital cytomegalovirus infection.
    The Journal of pediatrics, 1972, Volume: 80, Issue:3

    Topics: Agranulocytosis; Cytarabine; Cytomegalovirus; Cytomegalovirus Infections; Female; Humans; Infant; Infant, Newborn; Male; Thrombocytopenia; Vomiting

1972
Cytosine arabinoside (NSC 63878) toxicity and antitumor acitivity in human solid tumors.
    Oncology, 1974, Volume: 29, Issue:3

    Topics: Adenocarcinoma; Anemia; Blood Cell Count; Blood Platelets; Bone Neoplasms; Breast Neoplasms; Cytarabine; Dose-Response Relationship, Drug; Female; Gastrointestinal Neoplasms; Hemoglobinometry; Humans; Injections, Intravenous; Leukopenia; Male; Nausea; Sarcoma; Thrombocytopenia; Vomiting

1974
Combination chemotherapy of adult acute nonlymphoblastic leukemia.
    Annals of internal medicine, 1972, Volume: 76, Issue:3

    Topics: Acute Disease; Adolescent; Adult; Aged; Bone Marrow; Cytarabine; Drug Synergism; Female; Humans; Hydroxyurea; Leukemia; Leukemia, Myeloid; Leukemia, Myeloid, Acute; Male; Middle Aged; Nausea; Remission, Spontaneous; Thioguanine; Vomiting

1972
Cytosine arabinoside as a single agent in the therapy of adult acute leukemia.
    The American journal of the medical sciences, 1974, Volume: 268, Issue:3

    Topics: Administration, Oral; Adolescent; Adult; Age Factors; Aged; Anemia; Child; Cytarabine; DNA, Neoplasm; Female; Humans; Injections, Intravenous; Leukemia, Myeloid, Acute; Leukocytes; Male; Middle Aged; Muramidase; Nausea; Remission, Spontaneous; Sex Factors; Thioguanine; Thrombocytopenia; Time Factors; Vomiting

1974
1,3-Bis(2-chloroethyl)-1-nitrosourea (BCNU; NSC-409962) given alone and combined with antimetabolites in the treatment of advanced solid tumors.
    Cancer chemotherapy reports, 1972, Volume: 56, Issue:6

    Topics: Antineoplastic Agents; Breast Neoplasms; Colonic Neoplasms; Cystadenoma; Cytarabine; Female; Humans; Leukopenia; Lung Neoplasms; Male; Methotrexate; Nausea; Neoplasm Metastasis; Neoplasms; Nitrosourea Compounds; Ovarian Neoplasms; Stomach Neoplasms; Vomiting

1972
Multiple emulsions, a suitable vehicle to provide sustained release of cancer chemotherapeutic agents.
    British journal of pharmacology, 1972, Volume: 45, Issue:1

    Topics: Animals; Antineoplastic Agents; Cytarabine; Delayed-Action Preparations; Diarrhea; Emulsions; Lymphoma; Methotrexate; Mice; Neoplasms, Experimental; Pharmaceutical Vehicles; Rats; Vinblastine; Vomiting

1972
Cytosine arabinoside in acute leukemia of childhood.
    Cancer, 1971, Volume: 28, Issue:4

    Topics: Child; Cytarabine; Humans; Leukemia, Lymphoid; Leukemia, Myeloid, Acute; Leukopenia; Remission, Spontaneous; Thrombocytopenia; Vomiting

1971
Cytosine arabinoside therapy for acute myeloid leukaemia in adults.
    The New Zealand medical journal, 1971, Volume: 74, Issue:471

    Topics: Abdomen; Adolescent; Adult; Aged; Alopecia; Bone Marrow Diseases; Chemical and Drug Induced Liver Injury; Cytarabine; Diarrhea; Erythrocytes; Female; Fever; Humans; Infusions, Parenteral; Injections, Intravenous; Kidney Diseases; Leukemia, Myeloid, Acute; Male; Middle Aged; Nausea; Ulcer; Vomiting

1971
Treatment of adult leukemia with L-asparaginase (NSC-109229).
    Cancer chemotherapy reports, 1971, Volume: 55, Issue:3

    Topics: Adolescent; Adult; Aged; Allopurinol; Anaphylaxis; Asparaginase; Blood Coagulation Disorders; Cytarabine; Daunorubicin; Drug Hypersensitivity; Female; Fever; Gastrointestinal Hemorrhage; Hallucinations; Humans; Hyperglycemia; Injections, Intravenous; Jaundice; Leukemia, Lymphoid; Leukemia, Myeloid, Acute; Liver; Male; Mercaptopurine; Methotrexate; Middle Aged; Oral Hemorrhage; Prednisone; Thioguanine; Uremia; Vincristine; Vomiting

1971
The treatment of polycythemia vera with cytosine arabinoside.
    Arzneimittel-Forschung, 1967, Volume: 17, Issue:8

    Topics: Adult; Aged; Cytarabine; Humans; Middle Aged; Nausea; Polycythemia Vera; Vomiting

1967